Using active methicillin-resistant Staphylococcus aureus surveillance nasal swabs to predict clinical respiratory culture results

American Journal of Health-System Pharmacy

Volumn 72, Issue 11, 2015, Pages S20-S24

  Hiett, Jason ^a   Patel, Rupal K ^a,b   Tate, Victoria ^a   Smulian, George ^a   Kelly, Allison ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Bay Pines VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; AIRWAY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; NULL RESULT; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VETERAN; AGED; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGY; NOSE; PROCEDURES; PUBLIC HOSPITAL; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

AGED; HOSPITALS, VETERANS; HUMANS; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NOSE; PREDICTIVE VALUE OF TESTS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS;

EID: 84957886988     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/AJHP140820     Document Type: Article

References (10)

1. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. CID. 2007; 44:S27-72.
2. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171:388-416.
3. Muto CA, Jernigan JA, Ostrowsky BE et al. SHEA guideline for preventing nosocomial transmission of multidrugresistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003; 24:362-86.
4. Cincinnati VA Medical Center. Methicillin-resistant Staphylococcus aureus (MRSA) active surveillance testing and isolation policy (June 2010). https://vaww.v10.r03.portal.va.gov/sites/Cincinnati/Cincinnati Policies/11-96.docx (accessed 2012 Aug 21).
5. Calfee DP, Salgado CD, Classen D et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29:S62-80.
6. Pirracchio R, Mateo J, Raskine L et al. Can bacteriological upper airway samples obtained at intensive care unit admission guide empiric antibiotic therapy for ventilator-associated pneumonia? Crit Care Med. 2009; 37:2559-63.
7. Harris AD, Furuno JP, Roghmann MC et al. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother. 2010; 54:3143-8.
8. Chan JD, Dellit TH, Choudhuri JA et al. Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med. 2012; 40:1437-42.
9. Jinno S, Chang S, Donskey CJ et al. A negative nares screen in combination with absence of clinical risk factors can be used to identify patients with very low likelihood of methicillin-resistant Staphylococcus aureus infection in a Veterans Affairs hospital. Am J Infect Control. 2012; 40:782-6.
10. Boyce JM, Pop OF, Abreu-Lanfranco O et al. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother. 2013; 57:1163-8.